Osteoblast-derived TGF-β1 modulates matrix degrading protease expression and activity in prostate cancer cells

This publication has 22 references indexed in Scilit:

• Transforming growth factor-β enhances adhesion of melanoma cells to the endotheliumin vitro
  International Journal of Cancer, 1997
• Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells
  Cancer, 1995
• Thrombospondin (TSP) and Transforming Growth Factor β 1 (TGF-β) Promote Human A549 Lung Carcinoma Cell Plasminogen Activator Inhibitor Type 1 (Pal-1) Production and Stimulate Tumor Cell Attachment in Vitro
  Biochemical and Biophysical Research Communications, 1994
• Role of active and latent transforming growth factor β in bone formation
  Journal of Cellular Biochemistry, 1994
• Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells
  Journal of Cellular Physiology, 1993
• Negative regulation of gene expression by TGF‐β
  Molecular Reproduction and Development, 1992
• Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast Cancer
  Seminars in Thrombosis and Hemostasis, 1991
• Differential effects of transforming growth factor β on human prostate cancer cells in vitro
  Molecular and Cellular Endocrinology, 1989
• Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta
  The Journal of cell biology, 1988
• Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro.
  The Journal of cell biology, 1987